On this episode of Stock Movers:

- Oracle (ORCL) sees a 7% boost after it was announced that they would be leading a group of buyers in purchasing TikTok.

- Nike (NKE) is down for the fourth day in a row with an 11% drop today. Sales are continuing to decline, citing difficulty in China as well as their Converse brand.

- BioMarin Pharmaceutical (BMRN) is up big at 17% with their agreement to buy Amicus Pharmaceutics, helping expand their treatments for rare diseases.

On this episode of Stock Movers:
- Oracle (ORCL) sees a 7% boost after it was announced that they would be leading a group of buyers in purchasing TikTok.
- Nike (NKE) is down for the fourth day in a row with an 11% drop today. Sales are continuing to decline, citing difficulty in China as well as their Converse brand.
- BioMarin Pharmaceutical (BMRN) is up big at 17% with their agreement to buy Amicus Pharmaceutics, helping expand their treatments for rare diseases.

Listen for five-minute conversations on today's biggest winners and losers in the stock market. 

Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for five-minute conversations on today's biggest winners and losers in the stock market.&nbsp;
Subscribe for analysis on the companies making news in global equity markets. Episodes are published throughout the day to track stock moves from New York, London, Frankfurt and Paris. Join us for investment news covering technology, energy, finance, health care, communications, industrials, utilities, consumer staples, materials, real estate and more.

Listen for news on today's biggest winners and losers in the stock market.

Stock Movers

Oracle Rises, Nike Continues Fall, BioMarin Up Big After Acquisition

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6562e7e8-64ca-4427-a0b1-b3b8014a6c15/transcript

Today's biggest winners and losers in the stock market.
 
On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners from this past week:

- Nvidia (NVDA) projected sales growth of 70% for the next fiscal year, far outstripping the average analyst estimate of 45%. The company added about $442 billion in market value, after Chief Financial Officer Colette Kress said Nvidia would be growing even faster if it had access to more supplies. Nvidia's upbeat outlook offered relief to investors concerned about a bubble in the AI economy, with Chief Executive Officer Jensen Huang saying demand is only accelerating and the company's latest chip line, Vera Rubin, was built to power the current moment.

- Shares of Paypal (PYPL) plummeted ahead of the close after a consortium of buyout firm Advent and payment processor Stripe decided to abandon its pursuit of fintech pioneer. The deal would have ranked as one of the biggest-ever leveraged buyouts, according to people familiar with the matter. PayPal shares dropped as much as 14.4% at the start of trading in New York on Friday, its steepest decline since February.

- Salesforce (CRM) jumped the most in six years after giving an outlook for strong revenue expansion and deepening its partnership with Anthropic PBC. The company expects revenue to accelerate in the second half of the year, with sales of about $11.5 billion in the fiscal third quarter, and current remaining performance obligations increasing about 14%. Salesforce announced an expanded partnership with Anthropic, integrating its products within the AI model Claude, and reported that its AI tool Agentforce is on track to contribute about $1.5 billion in revenue this year.

Today's biggest winners and losers in the stock market. &nbsp; On this episode of Stock Movers, we take a look at some of the biggest gainers and decliners from this past week: - Nvidia (NVDA) projected sales growth of 70% for the next fiscal year, far outstripping the average analyst estimate of 45%. The company added about $442 billion in market value, after Chief Financial Officer Colette Kress said Nvidia would be growing even faster if it had access to more supplies. Nvidia's upbeat outlook offered relief to investors concerned about a bubble in the AI economy, with Chief Executive Officer Jensen Huang saying demand is only accelerating and the company's latest chip line, Vera Rubin, was built to power the current moment. - Shares of Paypal (PYPL) plummeted ahead of the close after a consortium of buyout firm Advent and payment processor Stripe decided to abandon its pursuit of fintech pioneer. The deal would have ranked as one of the biggest-ever leveraged buyouts, according to people familiar with the matter. PayPal shares dropped as much as 14.4% at the start of trading in New York on Friday, its steepest decline since February. - Salesforce (CRM) jumped the most in six years after giving an outlook for strong revenue expansion and deepening its partnership with Anthropic PBC. The company expects revenue to accelerate in the second half of the year, with sales of about $11.5 billion in the fiscal third quarter, and current remaining performance obligations increasing about 14%. Salesforce announced an expanded partnership with Anthropic, integrating its products within the AI model Claude, and reported that its AI tool Agentforce is on track to contribute about $1.5 billion in revenue this year.

Weekly Roundup: Nvidia Reported, PayPal Plummeted, Salesforce Jumped

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6ca3e754-b1c2-49ae-a562-b4b4015c1532/transcript

Today's biggest winners and losers in the stock market.
On this episode of Stock Movers:

Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Emily Graffeo, Lisa Mateo, Tim Stenovec

- Gap (GAP) shares are soaring after the apparel retailer raised both its adjusted earnings per share and adjusted gross margin outlooks for the full year. The company also announced Michael Francis as the newest CEO of Old Navy, which posted a worse-than-feared comparable sales decline in the quarter.

- Shares of Affirm (AFRM) rallied in Friday trading to the highest intraday since September 2025 after the financial technology company forecast revenue for the first quarter that beat the average analyst estimate. Separately, the company and Shopify expanded their global partnership to launch Shop Pay Installments in Australia.

- Ulta Beauty (ULTA) shares drop on Friday as higher discounts and promotions weighed on the cosmetics retailer’s margins. Analysts said gross margins were underwhelming but noted guidance could be conservative

Today's biggest winners and losers in the stock market. On this episode of Stock Movers: Listen for comprehensive cross-platform coverage of the US market close as heard on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostic, Emily Graffeo, Lisa Mateo, Tim Stenovec - Gap (GAP) shares are soaring after the apparel retailer raised both its adjusted earnings per share and adjusted gross margin outlooks for the full year. The company also announced Michael Francis as the newest CEO of Old Navy, which posted a worse-than-feared comparable sales decline in the quarter. - Shares of Affirm (AFRM) rallied in Friday trading to the highest intraday since September 2025 after the financial technology company forecast revenue for the first quarter that beat the average analyst estimate. Separately, the company and Shopify expanded their global partnership to launch Shop Pay Installments in Australia. - Ulta Beauty (ULTA) shares drop on Friday as higher discounts and promotions weighed on the cosmetics retailer&rsquo;s margins. Analysts said gross margins were underwhelming but noted guidance could be conservative

Closing Bell: Gap Soars, Affirm Rallies, Ulta Beauty Drops

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/41a7a38c-20df-4cc9-8157-b4b4014e4811/transcript

Today’s biggest winners and losers in the stock market. 

On this episode of Stock Movers: 
Shares of Paypal (PYPL) plummeted ahead of the close after a consortium of buyout firm Advent and payment processor Stripe decided to abandon its pursuit of fintech pioneer. The deal would have ranked as one of the biggest-ever leveraged buyouts, according to people familiar with the matter. PayPal shares dropped as much as 14.4% at the start of trading in New York on Friday, its steepest decline since February. 
Shares of Affirm (AFRM) rallied in Friday trading to the highest intraday since September 2025 after the financial technology company forecast revenue for the first quarter that beat the average analyst estimate. Separately, the company and Shopify expanded their global partnership to launch Shop Pay Installments in Australia. 
ADRs of BioNTech (BNTX) slumped after the German biotech firm and partner Roche Holding AG abandoned a trial of a personalized cancer vaccine, dashing hopes that had been raised by a rival drugmaker’s recent success in the field. The companies made the decision after an independent board recommended discontinuing the trial, BioNTech said in a statement Friday. The drug is designed to use mRNA vaccine technology to train the immune system to attack cancer cells.

Today&rsquo;s biggest winners and losers in the stock market.&nbsp;
On this episode of Stock Movers:&nbsp;
<ul>
<li>Shares of Paypal (PYPL) plummeted ahead of the close after a consortium of buyout firm Advent and payment processor Stripe decided to abandon its pursuit of fintech pioneer. The deal would have ranked as one of the biggest-ever leveraged buyouts, according to people familiar with the matter. PayPal shares dropped as much as 14.4% at the start of trading in New York on Friday, its steepest decline since February.&nbsp;</li>
<li>Shares of Affirm (AFRM) rallied in Friday trading to the highest intraday since September 2025 after the financial technology company forecast revenue for the first quarter that beat the average analyst estimate. Separately, the company and Shopify expanded their global partnership to launch Shop Pay Installments in Australia.&nbsp;</li>
<li>ADRs of BioNTech (BNTX) slumped after the German biotech firm and partner Roche Holding AG abandoned a trial of a personalized cancer vaccine, dashing hopes that had been raised by a rival drugmaker&rsquo;s recent success in the field. The companies made the decision after an independent board recommended discontinuing the trial, BioNTech said in a statement Friday. The drug is designed to use mRNA vaccine technology to train the immune system to attack cancer cells.</li>
</ul>

Paypal Sinks on Abandoned Deal, Affirm Rallies, BioNTech Slumps

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/88b35b66-dcb9-4abb-b19c-b4b4013e917d/transcript

Oracle Rises, Nike Continues Fall, BioMarin Up Big After Acquisition

In 1 playlist(s)

Stock Movers

Social links

Follow podcast

Recent clips